Evidence map›Paper›PMID 30400886›Full record

SynthesisBMC endocrine disorders2018

Bisphenol A exposure and type 2 diabetes mellitus risk: a meta-analysis.

Semi Hwang, Jung-Eun Lim, Yoonjeong Choi, Sun Ha Jee

4 registry-linked trialsAbstract readMeta-Analysis
In one paragraph

Synthesis in BMC endocrine disorders, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 50 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05780047 nacompletednot on this mapstarted 2022, after this paper: background citation

Personalized Mobile Intervention to Reduce Exposure to Endocrine Disrupting Chemicals (EDCs) in Women of Child-Bearing Age and Their Partners

TypeinterventionalSponsorMillion Marker Wellness, Inc.Ran2022 to 2022Enrolled434ConditionsEndocrine Disrupting Chemicals, Environmental Exposure, Health Literacy, Bisphenol AArmsMail-in Urine Test for EDCs
NCT06450951 nacompletednot on this mapstarted 2024, after this paper: background citation

A Personalized Digital Intervention Program to Reduce Exposure to Endocrine Disrupting Chemicals Among a Child-Bearing Age Cohort

TypeinterventionalSponsorMillion Marker Wellness, Inc.Ran2024 to 2026Enrolled1,074ConditionsEnvironmental ExposureArmsUrinary EDC metabolite testing, Educational curriculum
NCT07461857 nacompletednot on this mapstarted 2025, after this paper: background citation

Minority-focused Environmental Health Education and Tracking (MEET) Pilot Study

TypeinterventionalSponsorMillion Marker Wellness, Inc.Ran2025 to 2026Enrolled151ConditionsEnvironmental ExposureArmsEducation curriculum
NCT07560579 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle Interventions to Lose Weight and Reduce EDC Exposure in Individuals With Overweight/Obesity

TypeinterventionalSponsorMillion Marker Wellness, Inc.Ran2025 to 2026Enrolled226ConditionsObesity &Amp, Amp, Amp, OverweightArmsEducational curriculum, Weight loss Application, Urinary EDC metabolite testing, Siphox clinic biomarker test, Weight loss reporting
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Endocrine disruptors, insulin resistance, and diabetes.Turkish journal of medical sciences · 2025
    Review
  15. Article
  16. Article
  17. Endocrine disrupting chemicals and obesity prevention: scoping review.Journal of health, population, and nutrition · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Semi HwangDepartment of Epidemiology and Health Promotion, Institute for Health Promotion, Graduate School of Public Health, Yonsei University, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.
Jung-Eun LimDepartment of Epidemiology and Health Promotion, Institute for Health Promotion, Graduate School of Public Health, Yonsei University, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.
Yoonjeong ChoiDepartment of Public Health, Graduate School, Yonsei University, Seoul, Republic of Korea.
Sun Ha JeeDepartment of Epidemiology and Health Promotion, Institute for Health Promotion, Graduate School of Public Health, Yonsei University, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea. jsunha@yuhs.ac.ORCID http://orcid.org/0000-0001-9519-3068

Funding

The Ministry of Food and Drug Safety 15162MFDS631
6 · The paper itself

Abstract

backgroundThis meta-analytic study explored the relationship between the risk of type 2 diabetes mellitus (T2DM) and bisphenol A concentrations.

methodsThe Embase and Medline (PubMed) databases were searched, using relevant keywords, for studies published between 1980 and 2018. A total of 16 studies, twelve cross-sectional, two case-control and one prospective, were included in the meta-analysis. The odds ratio (OR) and its 95% confidence interval (CI) were determined across the sixteen studies. The OR and its 95% CI of diabetes associated with bisphenol A were estimated using both fixed-effects and random-effects models.

resultsA total of 41,320 subjects were included. Fourteen of the sixteen studies included in the analysis provided measurements of urine bisphenol A levels and two study provided serum bisphenol A levels. Bisphenol A concentrations in human bio-specimens showed positive associations with T2DM risk (OR 1.28, 95% CI 1.14, 1.44). A sensitivity analysis indicated that urine bisphenol A concentrations were positively associated with T2DM risk (OR 1.20, 95% CI 1.09, 1.31).

conclusionsThis meta-analysis indicated that Bisphenol A exposure is positively associated with T2DM risk in humans.

Indexed as

Benzhydryl CompoundsBisphenol A CompoundsBlood GlucoseCase-Control StudiesCross-Sectional StudiesDiabetes Mellitus, Type 2Environmental ExposureEstrogens, Non-SteroidalHumansPhenolsBenzhydryl Compoundsbisphenol ABisphenol A CompoundsBlood GlucoseEstrogens, Non-SteroidalPhenolsBisphenol a (BPA)Diabetes mellitus (DM)Endocrine disrupting chemicals (EDCs)Fasting plasma glucoseHemoglobin A1c (HbA1c)Meta-analysisObesityType 2 diabetes mellitus (T2DM)

Identifiers

PMID30400886
PMCPMC6219165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.